Tadalafil Citrate API: Erectile Dysfunction and BPH Treatment
Tadalafil is a long‑acting phosphodiesterase type 5 inhibitor. This API article summarises therapeutic uses, mechanism, and formulation considerations.
Overview of Tadalafil Citrate API
Tadalafil is a selective phosphodiesterase type 5 (PDE5) inhibitor indicated for erectile dysfunction (ED), benign prostatic hyperplasia (BPH), and pulmonary arterial hypertension (as specific formulations). The citrate form is one of the API variants used for oral tablet production.
Therapeutic Uses
- On‑demand or once‑daily treatment of erectile dysfunction
- Management of lower urinary tract symptoms associated with BPH
- Certain pulmonary arterial hypertension regimens (market‑dependent)
API and Formulation Considerations
High‑quality Tadalafil API must have controlled polymorphic form, particle size, and impurity profile to ensure predictable dissolution and bioavailability. Finished tablets are often film‑coated for stability and patient convenience.
Share this article:
About Vubrix Pharma Team
Our team of pharmacists and medical writers share accurate, easy-to-understand medicine information for healthcare professionals and patients.
Related Articles
Aripiprazole API: Uses, Pharmacology, and Quality Specifications
Learn about Aripiprazole active pharmaceutical ingredient (API) – indications, mechanism of action, typical finished dosage forms, and key quality parameters for reliable sourcing.
Fluconazole API: Antifungal Uses, Dosage Forms, and Quality Parameters
Discover key information about Fluconazole active pharmaceutical ingredient (API), including indications, mechanism of action, typical dosage forms, and quality expectations.
Aceclofenac API: NSAID Uses, Formulations, and Safety Highlights
Technical and clinical overview of Aceclofenac API, a widely used NSAID for pain and inflammation, including its mechanism, indications, and formulation considerations.